United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-1760_59908c27-3aaf-6fce-e063-6394a90a7e0e
- Product NDC
- 70518-1760
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190101
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BLISTER PACK (70518-1760-0) · 70518-1760-0
- 30 CAPSULE in 1 BLISTER PACK (70518-1760-4) · 70518-1760-4
- 60 CAPSULE in 1 BOTTLE, PLASTIC (70518-1760-5) · 70518-1760-5
- 90 CAPSULE in 1 BOTTLE, PLASTIC (70518-1760-6) · 70518-1760-6
- 120 CAPSULE in 1 BOTTLE, PLASTIC (70518-1760-8) · 70518-1760-8
- 30 CAPSULE in 1 BOTTLE, PLASTIC (70518-1760-9) · 70518-1760-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →